BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver functionGennaro Daniele, Bruno Daniele, Domenico Bilancia et al.|Hepatoma Research|2021Cited by 5
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo A. Ascierto et al.|Journal of Translational Medicine|2021Cited by 1